Zobrazeno 1 - 10
of 30
pro vyhledávání: '"GUIMARÃES, A.H.C."'
Autor:
RIJKEN, D.C. *, KOCK, E.L., GUIMARÃES, A.H.C., TALENS, S., MURAD, S. DARWISH, JANSSEN, H.L.A., LEEBEEK, F.W.G.
Publikováno v:
In Journal of Thrombosis and Haemostasis October 2012 10(10):2116-2122
Autor:
DE BRUIJNE, E.L.E. *, GILS, A., GUIMARÃES, A.H.C., DIPPEL, D.W.J., DECKERS, J.W., VAN DEN MEIRACKER, A.H., POLDERMANS, D., RIJKEN, D.C., DECLERCK, P.J., DE MAAT, M.P.M., LEEBEEK, F.W.G.
Publikováno v:
In Journal of Thrombosis and Haemostasis June 2009 7(6):919-927
Autor:
EMONTS, M., DE BRUIJNE, E.L.E., GUIMARÃES, A.H.C., DECLERCK, P.J., LEEBEEK, F.W.G., DE MAAT, M.P.M., RIJKEN, D.C., HAZELZET, J.A. *, GILS, A.
Publikováno v:
In Journal of Thrombosis and Haemostasis February 2008 6(2):268-276
BACKGROUND Subclinical leaflet thickening and reduced leaflet motion of bioprosthetic aortic valves have been documented by four-dimensional computed tomography (CT). Whether anticoagulation can reduce these phenomena after transcatheter aortic-valve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::63bf784a1417d25ed200e424f7d85374
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104861
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104861
BACKGROUND Whether the direct factor Xa inhibitor rivaroxaban can prevent thromboembolic events after transcatheter aortic-valve replacement (TAVR) is unclear. METHODS We randomly assigned 1644 patients without an established indication for oral anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::bdcc0993327bcf37e0fb1826d345102c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104863
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104863
Autor:
LEEBEEK, F.W.G. *, VAN GOOR, M.P.J., GUIMARAES, A.H.C., BROUWERS, G.J., DE MAAT, M.P.M., DIPPEL, D.W.J., RIJKEN, D.C.
Publikováno v:
In Journal of Thrombosis and Haemostasis October 2005 3(10):2211-2218
Publikováno v:
In Journal of Thrombosis and Haemostasis May 2004 2(5):780-784
Autor:
Guimarães, A.H.C., Laurens, N., Weijers, E.M., Koolwijk, P., Hinsbergh, V.W.M. van, Rijken, D.C.
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology, 10, 27, 2157-2162
OBJECTIVE - Besides having a key role in fibrinolysis, the plasminogen system has been implicated in cell migration and angiogenesis. A common mechanism is the binding of plasminogen to carboxy-terminal lysine residues in partially degraded fibrin or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0438f4999068b5d426b2f734b93179ef
http://resolver.tudelft.nl/uuid:82016b3c-34d1-4287-ad19-08b74c737eca
http://resolver.tudelft.nl/uuid:82016b3c-34d1-4287-ad19-08b74c737eca
Autor:
Guimarães, A.H.C.
Publikováno v:
Guimarães, A H C 2006, ' Modulation of the plasminogen system by thrombin activatable fibrinolysis inhibitor (TAFI) ', PhD, Vrije Universiteit Amsterdam . < http://www.ubvu.vu.nl/fulltext/dissertaties/7348/mock_thesis_NL+EN_Guimaraes.pdf >
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e048facd851a6c6ecf4d0ab99091393b
https://research.vu.nl/en/publications/2cf6ac6e-19a0-484e-b943-f679eea4a74e
https://research.vu.nl/en/publications/2cf6ac6e-19a0-484e-b943-f679eea4a74e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.